| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF MEDICAL OFFICER | Stock Option (right to buy) | 65,352 | $520,855 | $7.97 | 15 Mar 2024 | Direct |
| Structure Therapeutics Inc. | CHIEF MEDICAL OFFICER | Ordinary Shares | 26,235 | 15 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 1 | $0 | 4/A | CHIEF MEDICAL OFFICER | 20 Mar 2024, 19:41 |
| GPCR | Structure Therapeutics Inc. | 15 Mar 2024 | 2 | $0 | 4 | CHIEF MEDICAL OFFICER | 19 Mar 2024, 16:46 |
| GPCR | Structure Therapeutics Inc. | 07 Feb 2023 | 1 | +$22,500 | 4 | Chief Medical Officer | 09 Feb 2023, 18:04 |
| GPCR | Structure Therapeutics Inc. | 02 Feb 2023 | 0 | $0 | 3 | Chief Medical Officer | 02 Feb 2023, 17:13 |